APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

His-Tag Antibody

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global His-Tag Antibody Market Outlook and Growth Opportunities 2026

Report ID 173998650419 December 2025191 pages

Choose your research edition.

Industry ResearchHis-Tag Antibody Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal His-Tag Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal His-Tag Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal His-Tag Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal His-Tag Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global His-Tag Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the His-Tag Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the His-Tag Antibody market include Aviva Systems Biology, Bio X Cell, BioLegend, Cell Signaling Technology, Columbia Biosciences, GeneTex, Medimabs, NSJ Bioreagents and OriGene, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global His-Tag Antibody market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of His-Tag Antibody and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents His-Tag Antibody revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global His-Tag Antibody market.

His-Tag Antibody Segment by Company

Aviva Systems Biology

Bio X Cell

BioLegend

Cell Signaling Technology

Columbia Biosciences

GeneTex

Medimabs

NSJ Bioreagents

OriGene

Proteintech

Santa Cruz Biotechnology

United States Biological

His-Tag Antibody Segment by Type

Polyclonal

Monoclonal

His-Tag Antibody Segment by Application

Immunofluorescence

Immunoprecipitation

Western Blot

Others

His-Tag Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global His-Tag Antibody status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the His-Tag Antibody key companies, revenue, market share, and recent developments.

3. To split the His-Tag Antibody breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions His-Tag Antibody market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify His-Tag Antibody significant trends, drivers, influence factors in global and regions.

6. To analyze His-Tag Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global His-Tag Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of His-Tag Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of His-Tag Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global His-Tag Antibody industry.

Chapter 3: Detailed analysis of His-Tag Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of His-Tag Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of His-Tag Antibody in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. His-Tag Antibody Industry Trends Table 2. His-Tag Antibody Industry Drivers Table 3. His-Tag Antibody Industry Opportunities and Challenges Table 4. His-Tag Antibody Industry Restraints Table 5. Global His-Tag Antibody Revenue by Company (US$ Million) & (2021-2026) Table 6. Global His-Tag Antibody Revenue Share by Company (2021-2026) Table 7. Global His-Tag Antibody Company Ranking, (2024-2026) & (US$ Million) Table 8. Global His-Tag Antibody Key Company Manufacturing Base & Headquarters Table 9. Global His-Tag Antibody Company, Product Type & Application Table 10. Global His-Tag Antibody Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global His-Tag Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Polyclonal Table 15. Significant Companies of Monoclonal Table 16. Global His-Tag Antibody Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global His-Tag Antibody Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global His-Tag Antibody Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global His-Tag Antibody Sales Value Share by Type (2021-2026) Table 20. Global His-Tag Antibody Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Immunofluorescence Table 22. Significant Companies of Immunoprecipitation Table 23. Significant Companies of Western Blot Table 24. Significant Companies of Others Table 25. Global His-Tag Antibody Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global His-Tag Antibody Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global His-Tag Antibody Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global His-Tag Antibody Sales Value Share by Application (2021-2026) Table 29. Global His-Tag Antibody Sales Value Share by Application (2027-2032) Table 30. Global His-Tag Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global His-Tag Antibody Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global His-Tag Antibody Sales Value Share by Region (2021-2026) Table 33. Global His-Tag Antibody Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global His-Tag Antibody Sales Value Share by Region (2027-2032) Table 35. Global His-Tag Antibody Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global His-Tag Antibody Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global His-Tag Antibody Sales Value Market Share by Country (2021-2026) Table 38. Global His-Tag Antibody Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global His-Tag Antibody Sales Value Market Share by Country (2027-2032) Table 40. Aviva Systems Biology Company Information Table 41. Aviva Systems Biology Business Overview Table 42. Aviva Systems Biology His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Aviva Systems Biology His-Tag Antibody Product Portfolio Table 44. Aviva Systems Biology Recent Development Table 45. Bio X Cell Company Information Table 46. Bio X Cell Business Overview Table 47. Bio X Cell His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Bio X Cell His-Tag Antibody Product Portfolio Table 49. Bio X Cell Recent Development Table 50. BioLegend Company Information Table 51. BioLegend Business Overview Table 52. BioLegend His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. BioLegend His-Tag Antibody Product Portfolio Table 54. BioLegend Recent Development Table 55. Cell Signaling Technology Company Information Table 56. Cell Signaling Technology Business Overview Table 57. Cell Signaling Technology His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Cell Signaling Technology His-Tag Antibody Product Portfolio Table 59. Cell Signaling Technology Recent Development Table 60. Columbia Biosciences Company Information Table 61. Columbia Biosciences Business Overview Table 62. Columbia Biosciences His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Columbia Biosciences His-Tag Antibody Product Portfolio Table 64. Columbia Biosciences Recent Development Table 65. GeneTex Company Information Table 66. GeneTex Business Overview Table 67. GeneTex His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GeneTex His-Tag Antibody Product Portfolio Table 69. GeneTex Recent Development Table 70. Medimabs Company Information Table 71. Medimabs Business Overview Table 72. Medimabs His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Medimabs His-Tag Antibody Product Portfolio Table 74. Medimabs Recent Development Table 75. NSJ Bioreagents Company Information Table 76. NSJ Bioreagents Business Overview Table 77. NSJ Bioreagents His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. NSJ Bioreagents His-Tag Antibody Product Portfolio Table 79. NSJ Bioreagents Recent Development Table 80. OriGene Company Information Table 81. OriGene Business Overview Table 82. OriGene His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. OriGene His-Tag Antibody Product Portfolio Table 84. OriGene Recent Development Table 85. Proteintech Company Information Table 86. Proteintech Business Overview Table 87. Proteintech His-Tag Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Proteintech His-Tag Antibody Product Portfolio Table 89. Proteintech Recent Development Table 90. Santa Cruz Biotechnology Company Information Table 91. Santa Cruz Biotechnology Business Overview Table 92. Santa Cruz Biotechnology His-Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Santa Cruz Biotechnology His-Tag Antibody Product Portfolio Table 94. Santa Cruz Biotechnology Recent Development Table 95. United States Biological Company Information Table 96. United States Biological Business Overview Table 97. United States Biological His-Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. United States Biological His-Tag Antibody Product Portfolio Table 99. United States Biological Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. His-Tag Antibody Product Image Figure 2. Global His-Tag Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global His-Tag Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global His-Tag Antibody Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Polyclonal Image Figure 8. Monoclonal Image Figure 9. Global His-Tag Antibody Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global His-Tag Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global His-Tag Antibody Sales Value Share by Type (2021-2032) Figure 12. Immunofluorescence Image Figure 13. Immunoprecipitation Image Figure 14. Western Blot Image Figure 15. Others Image Figure 16. Global His-Tag Antibody Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global His-Tag Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global His-Tag Antibody Sales Value Share by Application (2021-2032) Figure 19. Global His-Tag Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global His-Tag Antibody Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America His-Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 22. North America His-Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe His-Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 24. Europe His-Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific His-Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific His-Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America His-Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 28. South America His-Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa His-Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa His-Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt His-Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt His-Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt His-Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunofluorescence
  • Immunoprecipitation
  • Western Blot
  • Others
Companies covered
  • Aviva Systems Biology
  • Bio X Cell
  • BioLegend
  • Cell Signaling Technology
  • Columbia Biosciences
  • GeneTex
  • Medimabs
  • NSJ Bioreagents
  • OriGene
  • Proteintech
  • Santa Cruz Biotechnology
  • United States Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global His-Tag Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global His-Tag Antibody Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 His-Tag Antibody Market Dynamics
  1. 2.1 His-Tag Antibody Industry Trends
  2. 2.2 His-Tag Antibody Industry Drivers
  3. 2.3 His-Tag Antibody Industry Opportunities and Challenges
  4. 2.4 His-Tag Antibody Industry Restraints
3 His-Tag Antibody Market by Company
  1. 3.1 Global His-Tag Antibody Company Revenue Ranking in 2025
  2. 3.2 Global His-Tag Antibody Revenue by Company (2021-2026)
  3. 3.3 Global His-Tag Antibody Company Ranking (2024-2026)
  4. 3.4 Global His-Tag Antibody Company Manufacturing Base and Headquarters
  5. 3.5 Global His-Tag Antibody Company Product Type and Application
  6. 3.6 Global His-Tag Antibody Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global His-Tag Antibody Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 His-Tag Antibody Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 His-Tag Antibody Market by Type
  1. 4.1 His-Tag Antibody Type Introduction
  2. 4.1.1 Polyclonal
  3. 4.1.2 Monoclonal
  4. 4.2 Global His-Tag Antibody Sales Value by Type
  5. 4.2.1 Global His-Tag Antibody Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global His-Tag Antibody Sales Value by Type (2021-2032)
  7. 4.2.3 Global His-Tag Antibody Sales Value Share by Type (2021-2032)
5 His-Tag Antibody Market by Application
  1. 5.1 His-Tag Antibody Application Introduction
  2. 5.1.1 Immunofluorescence
  3. 5.1.2 Immunoprecipitation
  4. 5.1.3 Western Blot
  5. 5.1.4 Others
  6. 5.2 Global His-Tag Antibody Sales Value by Application
  7. 5.2.1 Global His-Tag Antibody Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global His-Tag Antibody Sales Value by Application (2021-2032)
  9. 5.2.3 Global His-Tag Antibody Sales Value Share by Application (2021-2032)
6 His-Tag Antibody Regional Value Analysis
  1. 6.1 Global His-Tag Antibody Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global His-Tag Antibody Sales Value by Region (2021-2032)
  3. 6.2.1 Global His-Tag Antibody Sales Value by Region: 2021-2026
  4. 6.2.2 Global His-Tag Antibody Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America His-Tag Antibody Sales Value (2021-2032)
  7. 6.3.2 North America His-Tag Antibody Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe His-Tag Antibody Sales Value (2021-2032)
  10. 6.4.2 Europe His-Tag Antibody Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific His-Tag Antibody Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific His-Tag Antibody Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America His-Tag Antibody Sales Value (2021-2032)
  16. 6.6.2 South America His-Tag Antibody Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa His-Tag Antibody Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa His-Tag Antibody Sales Value Share by Country, 2025 VS 2032
7 His-Tag Antibody Country-level Value Analysis
  1. 7.1 Global His-Tag Antibody Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global His-Tag Antibody Sales Value by Country (2021-2032)
  3. 7.2.1 Global His-Tag Antibody Sales Value by Country (2021-2026)
  4. 7.2.2 Global His-Tag Antibody Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA His-Tag Antibody Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada His-Tag Antibody Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico His-Tag Antibody Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany His-Tag Antibody Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France His-Tag Antibody Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. His-Tag Antibody Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy His-Tag Antibody Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain His-Tag Antibody Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia His-Tag Antibody Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands His-Tag Antibody Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries His-Tag Antibody Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China His-Tag Antibody Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan His-Tag Antibody Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea His-Tag Antibody Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India His-Tag Antibody Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia His-Tag Antibody Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia His-Tag Antibody Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil His-Tag Antibody Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina His-Tag Antibody Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile His-Tag Antibody Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia His-Tag Antibody Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru His-Tag Antibody Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia His-Tag Antibody Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel His-Tag Antibody Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE His-Tag Antibody Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey His-Tag Antibody Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran His-Tag Antibody Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt His-Tag Antibody Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt His-Tag Antibody Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt His-Tag Antibody Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aviva Systems Biology
  2. 8.1.1 Aviva Systems Biology Company Information
  3. 8.1.2 Aviva Systems Biology Business Overview
  4. 8.1.3 Aviva Systems Biology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aviva Systems Biology His-Tag Antibody Product Portfolio
  6. 8.1.5 Aviva Systems Biology Recent Developments
  7. 8.2 Bio X Cell
  8. 8.2.1 Bio X Cell Company Information
  9. 8.2.2 Bio X Cell Business Overview
  10. 8.2.3 Bio X Cell His-Tag Antibody Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio X Cell His-Tag Antibody Product Portfolio
  12. 8.2.5 Bio X Cell Recent Developments
  13. 8.3 BioLegend
  14. 8.3.1 BioLegend Company Information
  15. 8.3.2 BioLegend Business Overview
  16. 8.3.3 BioLegend His-Tag Antibody Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioLegend His-Tag Antibody Product Portfolio
  18. 8.3.5 BioLegend Recent Developments
  19. 8.4 Cell Signaling Technology
  20. 8.4.1 Cell Signaling Technology Company Information
  21. 8.4.2 Cell Signaling Technology Business Overview
  22. 8.4.3 Cell Signaling Technology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cell Signaling Technology His-Tag Antibody Product Portfolio
  24. 8.4.5 Cell Signaling Technology Recent Developments
  25. 8.5 Columbia Biosciences
  26. 8.5.1 Columbia Biosciences Company Information
  27. 8.5.2 Columbia Biosciences Business Overview
  28. 8.5.3 Columbia Biosciences His-Tag Antibody Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Columbia Biosciences His-Tag Antibody Product Portfolio
  30. 8.5.5 Columbia Biosciences Recent Developments
  31. 8.6 GeneTex
  32. 8.6.1 GeneTex Company Information
  33. 8.6.2 GeneTex Business Overview
  34. 8.6.3 GeneTex His-Tag Antibody Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GeneTex His-Tag Antibody Product Portfolio
  36. 8.6.5 GeneTex Recent Developments
  37. 8.7 Medimabs
  38. 8.7.1 Medimabs Company Information
  39. 8.7.2 Medimabs Business Overview
  40. 8.7.3 Medimabs His-Tag Antibody Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Medimabs His-Tag Antibody Product Portfolio
  42. 8.7.5 Medimabs Recent Developments
  43. 8.8 NSJ Bioreagents
  44. 8.8.1 NSJ Bioreagents Company Information
  45. 8.8.2 NSJ Bioreagents Business Overview
  46. 8.8.3 NSJ Bioreagents His-Tag Antibody Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NSJ Bioreagents His-Tag Antibody Product Portfolio
  48. 8.8.5 NSJ Bioreagents Recent Developments
  49. 8.9 OriGene
  50. 8.9.1 OriGene Company Information
  51. 8.9.2 OriGene Business Overview
  52. 8.9.3 OriGene His-Tag Antibody Revenue and Gross Margin (2021-2026)
  53. 8.9.4 OriGene His-Tag Antibody Product Portfolio
  54. 8.9.5 OriGene Recent Developments
  55. 8.10 Proteintech
  56. 8.10.1 Proteintech Company Information
  57. 8.10.2 Proteintech Business Overview
  58. 8.10.3 Proteintech His-Tag Antibody Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Proteintech His-Tag Antibody Product Portfolio
  60. 8.10.5 Proteintech Recent Developments
  61. 8.11 Santa Cruz Biotechnology
  62. 8.11.1 Santa Cruz Biotechnology Company Information
  63. 8.11.2 Santa Cruz Biotechnology Business Overview
  64. 8.11.3 Santa Cruz Biotechnology His-Tag Antibody Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Santa Cruz Biotechnology His-Tag Antibody Product Portfolio
  66. 8.11.5 Santa Cruz Biotechnology Recent Developments
  67. 8.12 United States Biological
  68. 8.12.1 United States Biological Company Information
  69. 8.12.2 United States Biological Business Overview
  70. 8.12.3 United States Biological His-Tag Antibody Revenue and Gross Margin (2021-2026)
  71. 8.12.4 United States Biological His-Tag Antibody Product Portfolio
  72. 8.12.5 United States Biological Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst